These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 9292671

  • 1. Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery.
    Wedrich A, Menapace R, Ries E, Polzer I.
    J Cataract Refract Surg; 1997; 23(6):873-7. PubMed ID: 9292671
    [Abstract] [Full Text] [Related]

  • 2. Low-dose tissue plasminogen activator in the management of anterior chamber fibrin formation.
    Georgiadis N, Boboridis K, Halvatzis N, Ziakas N, Moschou V.
    J Cataract Refract Surg; 2003 Apr; 29(4):729-32. PubMed ID: 12686240
    [Abstract] [Full Text] [Related]

  • 3. Intracameral tissue plasminogen activator after glaucoma surgery. Indications, effectiveness, and complications.
    Lundy DC, Sidoti P, Winarko T, Minckler D, Heuer DK.
    Ophthalmology; 1996 Feb; 103(2):274-82. PubMed ID: 8594514
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Intraocular recombinant tissue-plasminogen activator fibrinolysis of fibrin formation after cataract surgery in children.
    Klais CM, Hattenbach LO, Steinkamp GW, Zubcov AA, Kohnen T.
    J Cataract Refract Surg; 1999 Mar; 25(3):357-62. PubMed ID: 10079440
    [Abstract] [Full Text] [Related]

  • 7. Intracameral r-tPA for the management of severe fibrinous reactions in TASS after cataract surgery.
    Osaadon P, Belfair N, Lavy I, Walter E, Levy J, Tuuminen R, Achiron A, Knyazer B.
    Eur J Ophthalmol; 2022 Jan; 32(1):200-204. PubMed ID: 33719630
    [Abstract] [Full Text] [Related]

  • 8. Effect of immediate postoperative intracameral tissue plasminogen activator (tPA) on anterior chamber fibrin formation in dogs undergoing phacoemulsification.
    Mancuso LA, Nadelstein B, Berdoulay A, Spatola RA.
    Vet Ophthalmol; 2019 Jul; 22(4):477-484. PubMed ID: 30773778
    [Abstract] [Full Text] [Related]

  • 9. The use of recombinant tissue plasminogen activator for intracameral fibrinolysis following cataract surgery.
    Wedrich A, Menapace R, Mühlbauer-Ries E.
    Int Ophthalmol; 2019 Jul; 18(5):277-80. PubMed ID: 7607808
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tissue plasminogen activator for the treatment of postoperative intraocular fibrinous membranes following cataract surgery.
    Schmitz K, Greite JH, Bartenschlager EM.
    Ger J Ophthalmol; 1995 Mar; 4(2):75-9. PubMed ID: 7795512
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of postcataract fibrinous membranes with tissue plasminogen activator.
    Moon J, Chung S, Myong Y, Chung S, Park C, Baek N, Rhee S.
    Ophthalmology; 1992 Aug; 99(8):1256-9. PubMed ID: 1513579
    [Abstract] [Full Text] [Related]

  • 14. Use of tissue plasminogen activator to revive blebs following intraocular surgery.
    Smith MF, Doyle JW.
    Arch Ophthalmol; 2001 Jun; 119(6):809-12. PubMed ID: 11405830
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intracameral tissue plasminogen activator to prevent severe fibrinous effusion after congenital cataract surgery.
    Siatiri H, Beheshtnezhad AH, Asghari H, Siatiri N, Moghimi S, Piri N.
    Br J Ophthalmol; 2005 Nov; 89(11):1458-61. PubMed ID: 16234453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.